Qu Biologics Inc.

14 records totalling $9,204,151.00 CAD, from official Government of Canada open data.

Embed this chart

Lobbying registry — possible match matched by name

An organization with this name appears in 3 federal lobbying registrations (0 currently active), between 2020 and 2020.

781242-367111-2 — Summa Strategies Canada 768275-367104-1 — Summa Strategies Canada Inc. 781242-367111-1 — Summa Strategies Canada

Matched automatically by organization name; a different organization with the same name is possible. The Registry of Lobbyists is the authoritative source. Lobbying is legal and regulated — this is context, not an allegation.

By department

Records

Qu Biologics Inc. $5,176,172.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2022-2023
Canada

This project will support a Phase 2, randomized, placebo-controlled clinical trial designed to test the effectiveness of a lung-directed immunomodulator on immune response, restoration of innate immun...

Qu Biologics Inc. $2,780,109.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2020-2021
Canada

This project will provide proof-of-concept evidence for the safety and efficacy for the prophylactic and therapeutic use of a lung-directed immunomodulator, to prevent serious COVID-19 infection.

National Research Council Canada | Conseil national de recherches Canada
FY 2012-2013
Canada
National Research Council Canada | Conseil national de recherches Canada
FY 2009-2010
Canada
National Research Council Canada | Conseil national de recherches Canada
FY 2009-2010
Canada
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2018-2019
Canada

This project aims to generate preclinical data showing that solid tumours can be better accessed and targeted by CAR T cells when the Firm's proprietary platform immunotherapy, Site-Specific Immunomod...

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

National Research Council Canada | Conseil national de recherches Canada
FY 2009-2010
Canada
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.

National Research Council Canada | Conseil national de recherches Canada
FY 2014-2015
Canada
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2020-2021
Canada

Develop processes and methods for quality control analytics and aseptic reagent and product handling, in preparation for commercial scale lot production of QBKPN, the Firm's lung-specific Site Specifi...

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

National Research Council Canada | Conseil national de recherches Canada
FY 2010-2011
Canada
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2024-2025
Canada

The Project will support development of intellectual property capacity within the Firm.